Exchange: NASDAQ·Updated 07:30 PM EDT
VOR logo

VOR Vor Biopharma Inc

$19.08
$0.75
(4.09%)
Today
Closed $19.08
$0.00
(0.00%)
After Hours
EarningsNov 12
Mkt Cap$1.08B
Vol1.07M

About VOR

Vor Biopharma, Inc. is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. It is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and potential commercialization to address serious autoantibody-driven conditions worldwide. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Boston, MA.
45

Neutral Sentiment

How do you feel about VOR?

Advertisement|Remove ads.